/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | OSCROscar Health, Inc. |
|---|---|
| Last close | $32.14close 2026-11-09 |
| Change % | +4.86%close 2026-11-09 |
| Market cap | $11.1Bclose 2026-11-09 |
| P/E | loss, no P/E |
| Revenue | $11.7B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2025-12-31 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | 27.5%FY to 2025-12-31 |
| Net income | $-443151000⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 Filing10-K · 0001568651-26-000011 · filed 2026-02-13 Open the filing on EDGAR →Open the XBRL payload →CiteOscar Health, Inc. (OSCR), us-gaap:NetIncomeLoss: -443,151,000 USD, fiscal year ended 2025-12-31. Form 10-K, accession 0001568651-26-000011, filed 2026-02-13. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001568651/us-gaap/NetIncomeLoss.json |
| Net margin | -3.8%FY to 2025-12-31 |
| EPS (diluted) | $-1.69⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001568651-26-000011 · filed 2026-02-13 Open the filing on EDGAR →Open the XBRL payload →CiteOscar Health, Inc. (OSCR), us-gaap:EarningsPerShareDiluted: -1.69 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001568651-26-000011, filed 2026-02-13. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001568651/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 4FY to 2025-12-31 |
| Altman Z-ScoreUNVALIDATED | 0.27FY to 2025-12-31 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | 02-04 → 02-14 |